Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Valneva's stock is trading at 2.83 euros this Monday late morning, up 2.39% from Friday's close. This technical rebound follows a dramatic collapse of…
Valneva has announced its participation in several events at the 26th World Vaccine Congress, which will be held from March 31 to April 2, 2026, in Wa…
Stifel ajuste sa position sur Valneva ce mardi 24 mars 2026.
Pfizer and Valneva announced on Monday the positive results of the phase 3 VALOR clinical trial of their Lyme disease vaccine candidate. The companies…
The French vaccine laboratory recorded an operational loss of €82.1 million in 2025, despite a 3% increase in revenue to €174.7 million. This contradi…
Valneva shares have significantly retreated this Thursday, dropping 3.34% to 4.624 euros during the session, in a Parisian market that is also trendin…
Valneva fell by 2.92% this Wednesday in session, trading at 4.782 euros, in a downward trending Parisian market. This decline follows a particularly s…
Valneva's stock price marked a significant increase of 6.16% this Tuesday during the session, reaching €4.97, in a Parisian market trending upwards wi…
Valneva is losing ground this Friday midday, continuing a negative week for the Nantes-based vaccine specialist's stock. The share price stands at 4.5…
Valneva sees a notable increase this Thursday, March 5, with shares trading at 4.794 euros mid-session, up 2.3% from the previous day's close. This ri…
